C

Cedar Crosse Research Center | Chicago, IL

Research site

(Unclaimed)

Location

800 S.Wells, Suite M15, Chicago, Illinois, United States of America

Site insights

Top conditions

Top treatments

Dapagliflozin

Empagliflozin

BMS-512148

PS433540

Ramipril

ABP-450

Metformin

Firibastat

Thiazolidinedione

Polypill

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 39 total trials

A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

This study is open to adults who are at least 18 years old and have a body mass index (BMI)bof 27 kg/m2 or more. People can take part if they have ca...

Enrolling

Obesity

Drug: Placebo

Drug: survodutide

Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)

A Phase 1/ 2 Randomized, Double-Blind, Placebo-Controlled Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokine...

Active, not recruiting

Type 2 Diabetes Mellitus

Drug: BMF-219